Adding value with multi-channel interaction for customer experience
With multi-channel now established as a key consideration for life science companies, Richard Baderin, Head of Commercial Services at CHASE, shares why an ever-increasing...
Are technological solutions here to stay for the NHS?
Will the rapid growth in use of technological solutions within the NHS persist beyond the pandemic? On the basis of recent policy statements, it...
Revaluating the international distribution strategy of medical devices
The last year has been a difficult time for the medical sector, facing unprecedented strain and major shortages of key medical equipment and personal...
Expand and evolve – when specialist services meet
Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
New NHS operational planning guidance – what does it mean for pharma?
Why is the new NHS operational planning guidance so significant and what does it mean for pharmaceutical companies? Oli Hudson, Content Director at Wilmington...
COVID-19 and key changes one year on
One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
Ashfield shakes up healthcare services with advanced integrated offering
Ashfield, part of UDG Healthcare plc, has announced the formation of three business units to bolster its integrated healthcare services across strategic consulting, benchmarking,...
The coming AI and data revolution in life sciences
Pharmafield is proud to announce a new, free webinar called ‘The coming AI and data revolution in healthcare’, where a panel (including Janssen, OKRA...
Don’t fall for the ‘next best action’ trap – AI in pharma sales
Pf is proud to announce a new, free webinar with OKRA focused on AI in pharma sales. Called ‘Why Next Best Action is not...
Building the trust – post COVID-19
Simon Grime, Executive Director at Wilmington Healthcare discusses what needs to be done to build trust between pharma and health in a post COVID-19...
Latest articles
Enter today! The Pf Awards 2022 are officially open
New Year | New Suite of Categories | New Candidates
Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
New study to explore if talazoparib could treat metastatic breast cancer
A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250m winter access fund for GPs to boost face to face appointments
The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
Adapting for success: Understanding commercial optimisation
How do you best align your field force with the changing landscape within the NHS? Oli Hudson, Content Director at Wilmington Healthcare, outlines the...
Positive SMC decision for first long-acting injectable HIV treatment
ViiV Healthcare has announced that the Scottish Medicines Consortium (SMC) has accepted Vocabria▼ (cabotegravir long-acting injection) in combination with Rekambys▼ (rilpivirine long-acting injection) for...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...